| C48 | Demographic factors associated with continuation of oral anti-retroviral HIV pre-exposure prophylaxis at one and three months in Nairobi, Kenya | E-poster | Adherence to HIV prevention strategies |
| C35 | Demand creation and HIV self-testing delivery during COVID-19 contingency measures of physical distancing among adolescents' key population enrolled in PrEP in Brazil | On-demand oral abstract session | HIV prevention adaptations during COVID-19 |
| C25 | Demand creation and voluntary medical male circumcision during COVID-19 pandemic | E-poster | Male circumcision |
| C27 | Delivering PrEP to young women in a low-income setting in South Africa: lessons for providing both convenience and support | E-poster | PrEP |
| D86 | Delivering a virtual modular education session intervention to antenatal and postnatal adolescent girls and young women (AGYW) in South Africa through a teleconferencing platform | E-poster | Adolescent girls and young women |
| A21 | Defining CTL immunotherapy candidates against replication-competent and defective HIV | On-demand oral abstract session | Immunotherapy: Vaccines and antibodies |
| A45 | Defining an adipose tissue single cell atlas to understand metabolic disease in HIV | On-demand oral abstract session | Co-morbidities: Non-communicable diseases |
| B4 | Decline in HIV testing and changes in positivity rates during the COVID-19 pandemic | E-poster | HIV testing and retesting |
| D53 | Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok | E-poster | Strengthening social and behavioural data collection and analysis |
| A20 | Dasatinib inhibits provirus reactivation in patients co-infected with HIV and HCV | E-poster | Eliminating and silencing latency |